Ignite Creation Date:
2024-05-06 @ 12:47 AM
Last Modification Date:
2024-10-26 @ 10:54 AM
Study NCT ID:
NCT01658150
Status:
COMPLETED
Last Update Posted:
2018-12-05
First Post:
2012-07-12
Brief Title:
Evaluating Isradipine for Cognitive Enhancement in Schizophrenia and Schizoaffective Disorder
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Icahn School of Medicine at Mount Sinai
Organization Data
Organization:
Icahn School of Medicine at Mount Sinai
Class:
OTHER
Study ID:
GCO 12-0679
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Lead Sponsor Class:
OTHER
Responsible Party:
Katherine Burdick
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Icahn School of Medicine at Mount Sinai
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Brain Behavior Research Foundation | OTHER |